June 2022
Zhang Y, Banta A, Fu Y, John MM, Post A, Razavi M, Cavallaro J, Aazhang B, Lin Y (2022) RT-RCG: Neural network and accelerator search towards effective and real-time ECG reconstruction from intracardiac electrograms. J Emerg Technol Comput Syst 18:1–25. https://doi.org/10.1145/3465372
Letsou GV, Bolch CM, Hord EC, Altman WC, Leschinsky B, Criscione JC (2022) The CorInnova implantable cardiac assist system for direct cardiac compression. Rev Cardiovasc Med 23:211. https://doi.org/10.31083/j.rcm2306211
Zemzemi C, Phillips M, Vela DC, Hilvert NA, Racadio JM, Bader KB, Haworth KJ, Holland CK (2022) Effect of thrombin and incubation time on porcine whole blood clot elasticity and recombinant tissue plasminogen activator susceptibility. Ultrasound Med Biol 48:1567–1578. https://doi.org/10.1016/j.ultrasmedbio.2022.04.003
Virani SS, Ballantyne CM, Petersen LA (2022) Guideline-concordant statin therapy use in secondary prevention: should the medical community wait for divine intervention? J Am Coll Cardiol 79:1814–1817. https://doi.org/10.1016/j.jacc.2022.02.042
Valério RS, Generoso G, Fernandes JL, Nasir K, Hong JC, Bittencourt MS (2022) Cost-effectiveness of using the coronary artery calcium score in guiding therapeutic decisions in primary prevention in the Brazilian population. Arq Bras Cardiol 118:1126–1131. https://doi.org/10.36660/abc.20210347
Thomas SS, Wu J, Davogustto G, Holliday MW, Eckel-Mahan K, Verzola D, Garibotto G, Hu Z, Mitch WE, Taegtmeyer H (2022) SIRPα mediates IGF1 receptor in cardiomyopathy-induced by chronic kidney disease. Circ Res 101161CIRCRESAHA121320546. https://doi.org/10.1161/CIRCRESAHA.121.320546
Steinmetz LM, Coselli JS (2022) Endovascular repair in patients with Marfan syndrome: concerns amid controversy. Ann Vasc Surg S0890-5096(22)00236–9. https://doi.org/10.1016/j.avsg.2022.04.049
Rana JS, Virani SS, Moffet HH, Liu JY, Coghlan LA, Vasadia J, Ballantyne CM, Karter AJ (2022) Association of low-density lipoprotein testing after an atherosclerotic cardiovascular event with subsequent statin adherence and intensification. Am J Med 135:603–606. https://doi.org/10.1016/j.amjmed.2021.11.011
Peng X, Lian Z, Perrard X-YD, Xiao Y, Ni J, O’Brien V, Dong H, Pownall HJ, Ballantyne CM, Wu H (2022) Poloxamer 407 induces hypertriglyceridemia but decreases atherosclerosis in Ldlr-/- mice. Cells 11:1795. https://doi.org/10.3390/cells11111795
Pandey A, Segar MW, Singh S, Reeves G, O’Connor C, Pina I, Whellan D, Kraus W, Mentz R, Kitzman D (2022) Frailty status modifies the efficacy of exercise training among patients with chronic heart failure and reduced ejection fraction: an analysis from the HF-ACTION Trial. Circulation 101161CIRCULATIONAHA122059983. https://doi.org/10.1161/CIRCULATIONAHA.122.059983
Obisesan OH, Kou M, Wang FM, Boakye E, Honda Y, Uddin SMI, Dzaye O, Osei AD, Orimoloye OA, Howard-Claudio CM, Coresh J, Blumenthal RS, Hoogeveen RC, Budoff MJ, Matsushita K, Ballantyne CM, Blaha MJ (2022) Lipoprotein(a) and subclinical vascular and valvular calcification on cardiac computed tomography: the Atherosclerosis Risk in Communities Study. J Am Heart Assoc 11:e024870. https://doi.org/10.1161/JAHA.121.024870
Nazir S, Minhas AMK, Deshotels M, Kamat IS, Cheema T, Birnbaum Y, Moukarbel GV, Bozkurt B, Hemant R, Jneid H (2022) Outcomes and resource utilization in patients hospitalized with gastrointestinal bleeding complicated by types 1 and 2 myocardial infarction. Am J Med S0002-9343(22)00284–4. https://doi.org/10.1016/j.amjmed.2022.04.001
Myhre PL, Claggett B, Yu B, Skali H, Solomon SD, Røsjø H, Omland T, Wiggins KL, Psaty BM, Floyd JS, Selvin E, Ballantyne CM, Shah AM (2022) Sex and race differences in N-terminal pro-B-type natriuretic peptide concentration and absolute risk of heart failure in the community. JAMA Cardiol 7:623–631. https://doi.org/10.1001/jamacardio.2022.0680
Lang MF, Anton JM, Tolpin DA (2022) Complex anesthetic management of “simple” transcatheter aortic valve replacement. Tex Heart Inst J 49:e227863. https://doi.org/10.14503/THIJ-22-7863
Krittanawong C, Isath A, Rosenson RS, Khawaja M, Wang Z, Fogg SE, Virani SS, Qi L, Cao Y, Long MT, Tangney CC, Lavie CJ (2022) Alcohol consumption and cardiovascular health. Am J Med S0002-9343(22)00356–4. https://doi.org/10.1016/j.amjmed.2022.04.021
Khawaja M, Thakker J, Kherallah R, Kitakaze M, Jneid H, Angiolillo DJ, Birnbaum Y (2022) Antacid therapy in coronary artery disease and heart failure: Proton pump inhibitors vs. H2 receptor blockers. Cardiovasc Drugs Ther. https://doi.org/10.1007/s10557-022-07358-4
Holmes KW, Markwardt S, Eagle KA, Devereux RB, Weinsaft JW, Asch FM, LeMaire SA, Maslen CL, Song HK, Milewicz DM, Prakash SK, Guo D, Morris SA, Pyeritz RE, Milewski RC, Ravekes WJ, Dietz HC, Shohet RV, Silberbach M, Roman MJ, GenTAC Investigators (2022) Cardiovascular outcomes in aortopathy: GenTAC registry of genetically triggered aortic aneurysms and related conditions. J Am Coll Cardiol 79:2069–2081. https://doi.org/10.1016/j.jacc.2022.03.367
Gyöngyösi M, Pokushalov E, Romanov A, Perin E, Hare JM, Kastrup J, Fernández-Avilés F, Sanz-Ruiz R, Mathur A, Wojakowski W, Martin-Rendon E, Pavo N, Pavo IJ, Hemetsberger R, Traxler D, Spannbauer A, Haller PM (2022) Meta-analysis of percutaneous endomyocardial cell therapy in patients with ischemic heart failure by combination of individual patient data (IPD) of ACCRUE and publication-based aggregate data. J Clin Med 11:3205. https://doi.org/10.3390/jcm11113205
Grant MC, Lother SA, Engelman DT, Hassan A, Atluri P, Moosdorf R, Hayanga JA, Merritt-Genore H, Chatterjee S, Firstenberg MS, Hirose H, Higgins J, Legare J-F, Lamarche Y, Kass M, Mansour S, Arora RC (2022) Surgical triage and timing for patients with coronavirus disease: a guidance statement from the Society of Thoracic Surgeons. Ann Thorac Surg S0003-4975(22)00706–8. https://doi.org/10.1016/j.athoracsur.2022.05.001
Gaba P, Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Juliano RA, Jiao L, Doyle RT, Granowitz C, Tardif J-C, Giugliano RP, Martens FMAC, Gibson CM, Ballantyne CM, REDUCE-IT Investigators (2022) Prevention of cardiovascular events and mortality with icosapent ethyl in patients with prior myocardial infarction. J Am Coll Cardiol 79:1660–1671. https://doi.org/10.1016/j.jacc.2022.02.035
Florido R, Kwak L, Echouffo-Tcheugui JB, Zhang S, Michos ED, Nambi V, Goldberg RB, Hoogeveen RC, Lazo M, Gerstenblith G, Post WS, Blumenthal RS, Coresh J, Folsom AR, Selvin E, Ballantyne C, Ndumele CE (2022) Obesity, galectin-3, and incident heart failure: the ARIC study. J Am Heart Assoc 11:e023238. https://doi.org/10.1161/JAHA.121.023238
Cole SH, Wagner RD, Volk AS, Nemec MK, Preventza OA, La Cruz KD, Coselli JS, Izaddoost SA (2022) Thoracic aortic graft salvage after sternal wound infection with antibiotic beads and flap coverage. Plast Reconstr Surg Glob Open 10:e4371. https://doi.org/10.1097/GOX.0000000000004371
Cheong BYC, Wilson JM, Preventza OA, Muthupillai R (2022) Gadolinium-based contrast agents: updates and answers to typical questions regarding gadolinium use. Tex Heart Inst J 49:e217680. https://doi.org/10.14503/THIJ-21-7680
Chen TK, Surapaneni AL, Arking DE, Ballantyne CM, Boerwinkle E, Chen J, Coresh J, Köttgen A, Susztak K, Tin A, Yu B, Grams ME (2022) APOL1 kidney risk variants and proteomics. Clin J Am Soc Nephrol 17:684–692. https://doi.org/10.2215/CJN.14701121
Chattopadhyay A, Guan P, Majumder S, Kaw K, Zhou Z, Zhang C, Prakash SK, Kaw A, Buja LM, Kwartler CS, Milewicz DM (2022) Preventing cholesterol-induced perk (protein kinase rna-like endoplasmic reticulum kinase) signaling in smooth muscle cells blocks atherosclerotic plaque formation. Arterioscler Thromb Vasc Biol 101161ATVBAHA121317451. https://doi.org/10.1161/ATVBAHA.121.317451
Bird S, Chand M, Tran TL, Ali S, Awad SS, Cornwell LD, Schutz A, Jimenez E (2022) Evaluation of the addition of angiotensin II in patients with shock after cardiac surgery at a Veterans Affairs medical center. Ann Pharmacother 10600280221099928. https://doi.org/10.1177/10600280221099928
Ballantyne CM, Davis JW (2022) Exercise and mortality in heart disease cohorts: meta-analysis to augment available evidence. J Am Coll Cardiol 79:1701–1703. https://doi.org/10.1016/j.jacc.2022.02.037
Al Rifai M, Newby LK, Nair AP, Misra A, Rogers JG, Fedson S, Virani SS (2022) SGLT-2 inhibitors for patients with heart failure: what have we learned recently? Curr Atheroscler Rep. https://doi.org/10.1007/s11883-022-01038-2
Ballantyne CM, Banach M, Bays HE, Catapano AL, Laufs U, Stroes ESG, Robinson P, Lei L, Ray KK (2022) Long-term safety and efficacy of bempedoic acid in patients with atherosclerotic cardiovascular disease and/or heterozygous familial hypercholesterolemia (from the CLEAR Harmony Open-Label Extension Study). Am J Cardiol 174:1–11. https://doi.org/10.1016/j.amjcard.2022.03.020
Geng Y-J, Smolensky MH, Sum-Ping O, Hermida R, Castriotta RJ (2022) Circadian rhythms of risk factors and management in atherosclerotic and hypertensive vascular disease: Modern chronobiological perspectives of an ancient disease. Chronobiol Int 1–30. https://doi.org/10.1080/07420528.2022.2080557
Diaz P, Coughlin W, Lam W, Ermis P, Aguilar D, Ganduglia Cazaban CM, Agopian AJ (2022) Describing characteristics of adults with and without congenital heart defects hospitalized with COVID-19. Birth Defects Res. https://doi.org/10.1002/bdr2.2052
Segar MW, Patel KV, Hellkamp AS, Vaduganathan M, Lokhnygina Y, Green JB, Wan S-H, Kolkailah AA, Holman RR, Peterson ED, Kannan V, Willett DL, McGuire DK, Pandey A (2022) Validation of the WATCH-DM and TRS-HFDM Risk Scores to Predict the Risk of Incident Hospitalization for Heart Failure Among Adults With Type 2 Diabetes: A Multicohort Analysis. J Am Heart Assoc 11:e024094. https://doi.org/10.1161/JAHA.121.024094
Segar MW, Kolkailah AA, Frederich R, Pong A, Cannon CP, Cosentino F, Dagogo-Jack S, McGuire DK, Pratley RE, Liu C-C, Maldonado M, Liu J, Cater NB, Pandey A, Cherney DZI (2022) Mediators of ertugliflozin effects on heart failure and kidney outcomes among patients with type 2 diabetes. Diabetes Obes Metab. https://doi.org/10.1111/dom.14769
Jia X, Sun C, Nambi V, Virani SS, Taffet G, Boerwinkle E, Bressler J, Ndumele C, Windham BG, de Lemos JA, Matsushita K, McEvoy JW, Hoogeveen RC, Selvin E, Ballantyne CM (2022) Midlife determinants of healthy cardiovascular aging: The Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis 350:82–89. https://doi.org/10.1016/j.atherosclerosis.2022.04.028
Echouffo-Tcheugui JB, Daya N, Ndumele CE, Matsushita K, Hoogeveen RC, Ballantyne CM, Coresh J, Shah AM, Selvin E (2022) Diabetes, GDF-15 and incident heart failure: the atherosclerosis risk in communities study. Diabetologia 65:955–963. https://doi.org/10.1007/s00125-022-05678-6
Patel VD, Patel KH, Lakhani DA, Desai R, Mehta D, Mody P, Pruthi S (2021) Acute pericarditis in a patient with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a case report and review of the literature on SARS-CoV-2 cardiological manifestations. AME Case Rep 5:6. https://doi.org/10.21037/acr-20-90
Chatterjee S, Loor G, Shafii AE, Liao KK (2022) Commentary: Get up and go! Pushing the envelope in ambulatory extracorporeal membrane oxygenation. JTCVS Tech 13:135–136. https://doi.org/10.1016/j.xjtc.2022.04.001
Moon MR (2022) Commentary: Board certification as a prerequisite for independent practice: Who is to say? J Thorac Cardiovasc Surg S0022-5223(22)00609–2. https://doi.org/10.1016/j.jtcvs.2022.05.019
Díaz-Gómez JL (2022) Fluid tolerance, hemodynamic/organ congestion, or congestion cascade in the critically ill-A must-known evolving concept in 2022. J Crit Care 71:154071. https://doi.org/10.1016/j.jcrc.2022.154071
Gad MM, Elgendy IY, Saad AM, Mahmoud AN, Isogai T, Chahine J, Kadri AN, Ghanta R, Jimenez E, Kapadia SR, Jneid H (2022) Outcomes of transcatheter versus surgical aortic valve replacement in patients <60 years of age. Cardiovasc Revasc Med S1553-8389(22)00238-X. https://doi.org/10.1016/j.carrev.2022.05.008
Stainback R (2022) Final President’s Message- State of the ASE. J Am Soc Echocardiogr 35:A9–A11. https://doi.org/10.1016/j.echo.2022.04.004
Preventza O (2022) Discussion. J Thorac Cardiovasc Surg S0022-5223(22)00515–3. https://doi.org/10.1016/j.jtcvs.2022.03.042
Kachroo P, Kelly MO, Bakir NH, Cooper C, Braverman AC, Kouchoukos NT, Moon MR (2022) Impact of aortic valve effective height following valve-sparing root replacement on postoperative insufficiency and reoperation. J Thorac Cardiovasc Surg S0022-5223(22)00406–8. https://doi.org/10.1016/j.jtcvs.2022.02.065
Buja LM (2022) The history, science, and art of wine and the case for health benefits: perspectives of an oenophilic cardiovascular pathologist. Cardiovasc Pathol 60:107446. https://doi.org/10.1016/j.carpath.2022.107446
Tang L, Zhong Z, Lin Y, Yang Y, Wang J, Martin JF, Li M (2022) EPIXplorer: A web server for prediction, analysis and visualization of enhancer-promoter interactions. Nucleic Acids Res gkac397. https://doi.org/10.1093/nar/gkac397
Angelini P, Uribe C (2022) Critical update and discussion of the prevalence, nature, mechanisms of action, and treatment options in potentially serious coronary anomalies. Trends Cardiovasc Med S1050-1738(22)00074–3. https://doi.org/10.1016/j.tcm.2022.05.007
Preventza O (2022) Commentary: One size does not fit all: The landing zone of the frozen elephant trunk will be different for every patient, and we need to be safe. J Thorac Cardiovasc Surg S0022-5223(22)00512–8. https://doi.org/10.1016/j.jtcvs.2022.04.030
Mehta A, Jain V, Saeed A, Saseen JJ, Gulati M, Ballantyne CM, Virani SS (2022) Lipoprotein(a) and ethnicities. Atherosclerosis 349:42–52. https://doi.org/10.1016/j.atherosclerosis.2022.04.005
Schwartz GG, Ballantyne CM (2022) Existing and emerging strategies to lower Lipoprotein(a). Atherosclerosis 349:110–122. https://doi.org/10.1016/j.atherosclerosis.2022.04.020
Friede KA, Myers RA, Gales J, Zhbannikov I, Ortel TL, Shah SH, Kraus WE, Ginsburg GS, Voora D (2022) An antiplatelet response gene expression signature is associated with bleeding. Cardiovasc Res cvac079. https://doi.org/10.1093/cvr/cvac079